1
Country: China | Funding: $195M
Connect Biopharmaceuticals is a developer of novel immune modulators for the treatment of serious autoimmune diseases and inflammation.
Connect Biopharmaceuticals is a developer of novel immune modulators for the treatment of serious autoimmune diseases and inflammation.
2
Country: USA | Funding: $70M
Landos Biopharma is a developer of an oral first-in-class therapeutics designed to target autoimmune diseases.
Landos Biopharma is a developer of an oral first-in-class therapeutics designed to target autoimmune diseases.
3
Country: Israel | Funding: $3.9M
Exosomm develops food solutions based on natural milk exosomes. Exosomm’s first product is a food formula with a patented-based active anti-inflammatory effect designed for patients with inflammatory bowel diseases (Crohn´s & Colitis).
Exosomm develops food solutions based on natural milk exosomes. Exosomm’s first product is a food formula with a patented-based active anti-inflammatory effect designed for patients with inflammatory bowel diseases (Crohn´s & Colitis).
4
Country: USA | Funding: $2.2M
SmartTab is a digital medicine company which develops innovative wireless drug delivery and monitoring systems.
SmartTab is a digital medicine company which develops innovative wireless drug delivery and monitoring systems.
